Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2025-12-24 @ 12:31 PM
NCT ID:
NCT00415961
Eligibility Criteria:
Inclusion Criteria:
General Inclusion Criteria
* Eligible for percutaneous coronary intervention (PCI)
* Documented stable or unstable angina pectoris (Class I, II, III or IV), documented ischemia, or documented silent ischemia
* Documented LVEF ≥25% within the last 6 weeks.
* Eligible for coronary artery bypass graft surgery (CABG)
Exclusion Criteria:
General Exclusion Criteria: -
* Known sensitivity to paclitaxel or polymeric matrices.
* Planned treatment with any other PCI device in the target vessel(s).
* MI within 72 hours prior to the index procedure
* Patient is in cardiogenic shock
* Cerebrovascular Accident (CVA) within the past 6 months
* Acute or chronic renal dysfunction (creatinine \>2.0 mg/dl or \>150 µmol/L)
* Contraindication to ASA or to ticlopidine
* Thrombocytopenia
* Active GI bleeding within past three months
* Known allergy to cobalt chromium
* Any prior true anaphylactic reaction to contrast agents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
95 Years
Study:
NCT00415961
Study Brief:
Protocol Section:
NCT00415961